Medicus Pharma is selling for under 3.95 as of the 14th of December 2024; that is 6.76% up since the beginning of the trading day. The stock's lowest day price was 3.95. Medicus Pharma has less than a 18 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Medicus Pharma has reported 2 for 1 split on 28th of October 2024. The performance scores are derived for the period starting the 14th of November 2024 and ending today, the 14th of December 2024. Click here to learn more.
Medicus Pharma is entity of Canada. It is traded as Stock on V exchange. The company has 11.82 M outstanding shares of which 900 shares are now shorted by private and institutional investors with about 0.96 days to cover all short positions. More on Medicus Pharma
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medicus Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medicus Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Medicus Pharma (MDCX) is traded on TSX Venture Exchange in Canada and employs 4 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 46.68 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medicus Pharma's market, we take the total number of its shares issued and multiply it by Medicus Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medicus Pharma has 11.82 M outstanding shares of which 900 shares are now shorted by private and institutional investors with about 0.96 days to cover all short positions.
Medicus Pharma generates negative cash flow from operations
Check Medicus Pharma Probability Of Bankruptcy
Medicus Pharma Risk Profiles
Although Medicus Pharma's alpha and beta are two of the key measurements used to evaluate Medicus Pharma's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Medicus Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Analyst Advice Now
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.